Works by McQueen, R Brett

Results: 34

Incorporating real-world clinical practice in multiple sclerosis economic evaluations.

Published in:

2015

By:

Brett McQueen, R;
Nair, Kavita V;
Vollmer, Timothy L;
Campbell, Jonathan D;
McQueen, R Brett

Publication type:

Editorial

Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease.

Published in:

JAMA Neurology, 2024, v. 81, n. 1, p. 39, doi. 10.1001/jamaneurol.2023.4260

By:

Kluger, Benzi M.;
Katz, Maya;
Galifianakis, Nicholas B.;
Pantilat, Steven Z.;
Hauser, Joshua M.;
Khan, Ryan;
Friedman, Cari;
Vaughan, Christina L.;
Goto, Yuika;
Long, S. Judith;
Martin, Christine S.;
Dini, Megan;
McQueen, R. Brett;
Palmer, Laura;
Fairclough, Diane;
Seeberger, Lauren C.;
Sillau, Stefan H.;
Kutner, Jean S.

Publication type:

Article

Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information.

Published in:

2015

By:

Campbell, Jonathan D.;
McQueen, R. Brett;
Libby, Anne M.;
Spackman, D. Eldon;
Carlson, Joshua J.;
Briggs, Andrew

Publication type:

Journal Article

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap.

Published in:

Drug, Healthcare & Patient Safety, 2012, v. 4, p. 67, doi. 10.2147/DHPS.S32473

By:

Page II, Robert Lee;
Ghushchyan, Vahram;
Allen, Richard R.;
Roper, Lisa;
Beck, Don;
Jonathan, Bamrom H.;
Frech-Tamas, Feride;
Chan, Wing;
McQueen, R. Brett;
Nair, Kavita V.

Publication type:

Article

Capsule Commentary on Duru et al., Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).

Published in:

2015

By:

McQueen, R.;
McQueen, R Brett

Publication type:

journal article

On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections.

Published in:

2019

By:

Morrisette, Taylor;
Miller, Matthew A;
Montague, Brian T;
Barber, Gerard R;
McQueen, R Brett;
Krsak, Martin

Publication type:

journal article

Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs.

Published in:

Open Forum Infectious Diseases, 2019, v. 6, n. 7, p. N.PAG, doi. 10.1093/ofid/ofz274

By:

Morrisette, Taylor;
Miller, Matthew A;
Montague, Brian T;
Barber, Gerard R;
McQueen, R Brett;
Krsak, Martin

Publication type:

Article

Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins.

Published in:

American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 67, doi. 10.1007/s40256-022-00552-7

By:

McQueen, R. Brett;
Baum, Seth J.;
Louie, Michael J.;
Sasiela, William J.;
Bilitou, Aikaterini;
Shah, Hemal;
Nash, Beth;
Gillard, Kristin K.;
Ray, Kausik K.

Publication type:

Article

Fasting Blood Glucose-A Missing Variable for GFR-Estimation in Type 1 Diabetes?

Published in:

PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0096264

By:

Bjornstad, Petter;
McQueen, R. Brett;
Snell-Bergeon, Janet K.;
Cherney, David;
Pyle, Laura;
Perkins, Bruce;
Rewers, Marian;
Maahs, David M.

Publication type:

Article

Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access Model.

Published in:

PharmacoEconomics, 2025, v. 43, n. 5, p. 583, doi. 10.1007/s40273-025-01474-3

By:

Zemplenyi, Antal;
Leonard, Jim;
Wright, Garth C.;
DiStefano, Michael J.;
Nair, Kavita;
Anderson, Kelly E.;
McQueen, R. Brett

Publication type:

Article

Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid.

Published in:

PharmacoEconomics, 2024, v. 42, n. 3, p. 319, doi. 10.1007/s40273-023-01335-x

By:

Zemplenyi, Antal;
Leonard, Jim;
DiStefano, Michael J.;
Anderson, Kelly E.;
Wright, Garth C.;
Mendola, Nicholas D.;
Nair, Kavita;
McQueen, R. Brett

Publication type:

Article

Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable?

Published in:

PharmacoEconomics, 2023, v. 41, n. 3, p. 321, doi. 10.1007/s40273-022-01230-x

By:

McQueen, R. Brett;
Anderson, Kelly E.;
Levy, Joseph F.;
Carlson, Josh J.

Publication type:

Article

Correction to: Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease Therapies.

Published in:

2022

By:

Mattingly II, T. Joseph;
McQueen, R. Brett;
Lin, Pei-Jung

Publication type:

Correction Notice

Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease Therapies.

Published in:

PharmacoEconomics, 2021, v. 39, n. 10, p. 1101, doi. 10.1007/s40273-021-01079-6

By:

Mattingly II, T. Joseph;
McQueen, R. Brett;
Lin, Pei-Jung

Publication type:

Article

Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment.

Published in:

2021

By:

McQueen, R. Brett;
Slejko, Julia F.

Publication type:

Editorial

A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.

Published in:

PharmacoEconomics, 2020, v. 38, n. 11, p. 1201, doi. 10.1007/s40273-020-00949-9

By:

Gao, Wei;
Muston, Dominic;
Monberg, Matthew;
McLaurin, Kimmie;
Hettle, Robert;
Szamreta, Elizabeth;
Swallow, Elyse;
Zhang, Su;
Kalemaj, Iden;
Signorovitch, James;
McQueen, R. Brett

Publication type:

Article

What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society?

Published in:

2020

By:

McQueen, R. Brett

Publication type:

journal article

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.

Published in:

2019

By:

Carlson, Josh J.;
Walton, Surrey M.;
Basu, Anirban;
Chapman, Richard H.;
Campbell, Jonathan D.;
McQueen, R. Brett;
Pearson, Steven D.;
Touchette, Daniel R.;
Veenstra, David;
Whittington, Melanie D.;
Ollendorf, Daniel A.

Publication type:

journal article

Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".

Published in:

2019

By:

McQueen, R. Brett;
Whittington, Melanie D.;
Chapman, Rick H.;
Kumar, Varun M.;
Campbell, Jonathan D.

Publication type:

Letter

Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations.

Published in:

2018

By:

McQueen, R. Brett;
Sheehan, Danielle N.;
Whittington, Melanie D.;
van Boven, Job F. M.;
Campbell, Jonathan D.

Publication type:

journal article

Clinical and Financial Impact of Pharmacy Services in the Intensive Care Unit: Pharmacist and Prescriber Perceptions.

Published in:

Pharmacotherapy, 2013, v. 33, n. 4, p. 401, doi. 10.1002/phar.1226

By:

MacLaren, Robert;
Brett McQueen, R.;
Campbell, Jon

Publication type:

Article

A Call for Open-Source Cost-Effectiveness Analysis.

Published in:

2018

By:

McQueen, R. Brett;
Padula, William V.;
Campbell, Jonathan D.

Publication type:

Letter

The 'e' in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence.

Published in:

2014

By:

Campbell, Jonathan D;
McQueen, R Brett;
Briggs, Andrew

Publication type:

Journal Article

The "E" in Cost-Effectiveness Analyses.

Published in:

Annals of the American Thoracic Society, 2014, v. 11, n. Supp2, p. S105, doi. 10.1513/AnnalsATS.201309-295RM

By:

Campbell, Jonathan D.;
McQueen, R. Brett;
Briggs, Andrew

Publication type:

Article

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.

Published in:

JAMA Pediatrics, 2018, v. 172, n. 12, p. 1161, doi. 10.1001/jamapediatrics.2018.2530

By:

Whittington, Melanie D.;
McQueen, R. Brett;
Ollendorf, Daniel A.;
Kumar, Varun M.;
Chapman, Richard H.;
Tice, Jeffrey A.;
Pearson, Steven D.;
Campbell, Jonathan D.

Publication type:

Article

Considerations for Cost-effectiveness Analysis of Curative Pediatric Therapies.

Published in:

JAMA Pediatrics, 2018, v. 172, n. 5, p. 409, doi. 10.1001/jamapediatrics.2018.0049

By:

Whittington, Melanie D.;
McQueen, R. Brett;
Campbell, Jonathan D.

Publication type:

Article

Patient and Payer Preferences for Additional Value Criteria.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.690021

By:

Jakab, Ivett;
Whittington, Melanie D.;
Franklin, Elizabeth;
Raiola, Susan;
Campbell, Jonathan D.;
Kaló, Zoltán;
McQueen, R. Brett

Publication type:

Article

Identifying Sepsis From Foodborne Hospitalization: Incidence and Hospitalization Cost by Pathogen.

Published in:

Clinical Infectious Diseases, 2022, v. 75, n. 5, p. 857, doi. 10.1093/cid/ciab1045

By:

Ahn, Jae Wan;
Walter, Elaine Scallan;
White, Alice E;
McQueen, R Brett;
Hoffmann, Sandra

Publication type:

Article

Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado.

Published in:

2020

By:

McQueen, R. Brett;
Geno Rasmussen, Cristy;
Waugh, Kathleen;
Frohnert, Brigitte I.;
Steck, Andrea K.;
Yu, Liping;
Baxter, Judith;
Rewers, Marian

Publication type:

journal article

59-LB: The Impact of Glycemic Variability on the Relationship between Hypoglycemia and HbA1c.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-59-LB

By:

MCQUEEN, R. BRETT;
PEREZ-NIEVES, MAGALY;
ALONSO, GUY T.;
JUNEJA, RATTAN;
HANNAH, KATIA;
FAN, LUDI;
HANKOSKY, EMILY R.;
SHAH, VIRAL;
YAN, YU;
ELLIS, SAMUEL

Publication type:

Article

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.

Published in:

JAMA Network Open, 2019, v. 2, n. 2, p. e190035, doi. 10.1001/jamanetworkopen.2019.0035

By:

Whittington, Melanie D.;
McQueen, R. Brett;
Ollendorf, Daniel A.;
Kumar, Varun M.;
Chapman, Richard H.;
Tice, Jeffrey A.;
Pearson, Steven D.;
Campbell, Jonathan D.

Publication type:

Article

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta-Agonist.

Published in:

Pulmonary Therapy, 2016, v. 2, n. 1, p. 73, doi. 10.1007/s41030-016-0014-2

By:

Roche, Nicolas;
Colice, Gene;
Israel, Elliot;
Martin, Richard;
Dorinsky, Paul;
Postma, Dirkje;
Guilbert, Theresa;
Grigg, Jonathan;
Aalderen, Willem;
Barion, Francesca;
Hillyer, Elizabeth;
Thomas, Victoria;
Burden, Anne;
Brett McQueen, R.;
Price, David

Publication type:

Article

Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up.

Published in:

Multidisciplinary Respiratory Medicine, 2016, v. 11, p. 1, doi. 10.1186/s40248-016-0076-x

By:

Price, David B.;
van Boven, Job F. M.;
Law, Lisa M.;
Cifra, Alessandra;
Brett McQueen, R.

Publication type:

Article

Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments.

Published in:

2019

By:

Padula, William V.;
McQueen, R. Brett

Publication type:

Editorial